Document de conseils sur l'hydrate de chloral dans l'eau potable

Partie B - Renseignements de base

B.4 Bibliographie et acronymes

B.4.1 Références

• Abbas, R.R., Seckel, C.S., Kidney, J.K. et Fisher, J.W. (1996) Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Dispos., 24(12) : 1340-1346.
• Allen, B.C. et Fisher, J.W. (1993) Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal., 13 : 71-86.
• Allen, J.W., Collins, B.W. et Evansky, P.A. (1994) Spermatid micronucleus analyses of trichloroethylene and chloral hydrate effects in mice. Mutat. Res., 323(1-2) : 81-88.
• APHA (American Public Health Association), AWWA (American Water Works Association) et WEF (Water Environment Federation) (2005) Standards methods for the examination of water and wastewater. 21^e éd. Washington, DC. p. 5.70.
• Beland, F.A. (1999) NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0) administered by gavage to F344/N rats and B6C3F1 mice. Toxicity Report Series No. 59, National Toxicology Program, National Institutes of Health, Research Triangle Park, NC. p. 1-136.
• Beland, F.A., Schmitt, T.C., Fullerton, N.F. et Young, J.F. (1998) Metabolism of chloral hydrate in mice and rats after single and multiple doses. J. Toxicol. Environ. Health, 54 : 209-226.
• Benoit, F.M., LeBel, G.L. et Jay, B. (2000) Evaluation of remedial actions to reduce the levels of chlorinated disinfection by-products in drinking water at the point of use. Proceedings of the 9th National Conference on Drinking Water, Regina (Saskatchewan), 16-18 mai 2000.
• Bignami, M., Conti, G., Conti, L., Crebelli, R., Misuraca, F., Puglia, A.M., Randazzo, R., Sciandrello, G. et Carere, A. (1980) Mutagenicity of halogenated aliphatic hydrocarbons in Salmonella typhimurium, Streptomyces coelicolor and Aspergillus nidulans. Chem. Biol. Interact., 30 : 9-23.
• Bruce, W.R. et Heddle, J.A. (1979) The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella, and sperm abnormality assays. Can. J. Gen. Cytol., 21 : 319-334.
• Budavari, S. (1996) The Merck index. An encyclopedia of chemicals, drugs, and biologicals. 12^e éd. Merck and Co. Inc., Whitehouse Station, NJ.
• Butler, T.C. (1948) The metabolic fate of chloral hydrate. J. Pharmacol. Exp. Ther., 92 : 49-58.
• Chang, L.W., Daniel, F.B. et DeAngelo, A.B. (1992) Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acid and chlorinated acetaldehydes. Environ. Mol. Mutagen., 20(4) : 277-288.
• CIRC (Centre International de Recherche sur le Cancer) (1995) Chloral and chloral hydrate. IARC Monogr. Eval. Carcinogen. Risks Hum., 63: 245-269.
• Daniel, F.B., DeAngelo, A.B., Stober, J.A., Olson, G.R. et Page, N.P. (1992a) Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol., 19(2) : 159-168.
• Daniel, F.B., Robinson, M., Stober, J.A., Page, N.P. et Olson, G.R. (1992b) Ninety-day toxicity study of chloral hydrate in the Sprague-Dawley rat. Drug Chem. Toxicol., 15 : 217-232.
• Edsall, T.A. et Charlton, M.N. (1997) Nearshore waters of the Great Lakes. State of the Lakes Ecosystem Conference 1996. EPA 905-R-97-015A ( N^o catalogue En40-11/35-1-1-1997E).
• Ellenhorn, M.J. et Barceloux, D.G. (1988) Medical toxicology. Diagnosis and treatment of human poisoning. Elsevier Science Publishing Co., Inc., New York, NY.
• Ellenhorn, M.J., Schonwald, S., Ordog, G. et Wasserberger, J. (1997) Ellenhorn's medical toxicology: Diagnosis and treatment of human poisoning. 2^e éd. Williams and Wilkins, Baltimore, MD.
• George, M., Moore, T., Kilburn, S., Olson, G.R. et DeAngelo, A.B. (2000) Carcinogenicity of chloral hydrate administered in drinking water to the male F344/N rat and male B6C3F1 mouse. Toxicol. Pathol., 28 : 610-618.
• Gilman, A.G., Goodman, L.S. et Gilman, A. (1985) Chloral hydrate. Dans : Goodman et Gilman, The pharmacological basis of therapeutics. Macmillan, New York, NY. p. 352, 370.
• Greenberg, S.B., Faerber, E.N. et Aspinall, C.L. (1991) High-dose chloral hydrate sedation for children undergoing CT. J. Comput. Assist. Tomogr., 15 : 467-469.
• Gu, Z.W., Sele, B., Jalbert, P., Vincent, M., Vincent, F., Marka, C., Chmara, D. et Faure, J. (1981) Effets du trichloroéthylène et de ses métabolites sur le taux d'échanges de chromatides-soeurs. Toxicol. Eur. Res., 3(2) : 63-67.
• Hansch, C., Leo, A. et Hoekman, D. (1995) Exploring QSAR - Hydrophobic, electronic, and steric constants. American Chemical Society, Washington, DC.
• Harrington-Brock, K., Doerr, C.L. et Moore, M.M. (1998) Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/-(-)3.7.2C mouse lymphoma cells. Mutat. Res., 413(3) : 265-276.
• Haseman, J.K., Hailey, J.R. et Harris, R.W. (1998) Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol. Pathol., 26(3) : 428-441.
• Henderson, G.N., Yan, Z., James, M.O., Davydova, N. et Stacpoole, P.W. (1997) Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite. Biochem. Biophys. Res. Commun., 235 : 695-698.
• Johnson, P.D., Dawson, B.V. et Goldberg, S.J. (1998) Cardiac teratogenicity of trichloroethylene metabolites. J. Am. Coll. Cardiol., 32 : 540-545.
• Kallman, M.J., Kaempf, G.L. et Balster, R.L. (1984) Behavioral toxicity of chloral in mice: an approach to evaluation. Neurobehav. Toxicol. Teratol., 6 : 137-146.
• Kauffmann, B.M., White, K.L., Sanders, V.M., Douglas, K.A., Sain, L.E., Borzelleca, J.F. et Munson, A.E. (1982) Humoral and cell-mediated status in mice exposed to chloral hydrate. Environ. Health Perspect., 44 : 147-151.
• Ketcha, M.M., Stevens, D.K., Warren, D.A., Bishop, C.T. et Brashear, W.T. (1996) Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J. Anal. Toxicol., 20 : 236-241.
• Kirk-Othmer (1991) Kirk-Othmer encyclopedia of chemical technology. 4^e éd. Wiley Interscience, New York, NY.
• Klinefelter, G.R., Suarez, J.D., Roberts, N.L. et DeAngelo, A.B. (1995) Preliminary screening for the potential of drinking water disinfection by-products to alter male reproduction. Reprod. Toxicol., 9 : 571-578.
• Krasner, S.W., McGuire, M.J., Jacangelo, J.G., Patania, N.L., Reagan, K.M. et Aieta, E.M. (1989) The occurrence of disinfection by-products in US drinking water. J. Am. Water Works Assoc., 81(8) : 41-52.
• LeBel, G.L., Jay, B. et Benoit, F.M. (2002) Evaluation of filtration devices to reduce levels of chlorinated disinfection by-products (CDBPs) in drinking water at the point of use. Proceedings of the 10th National Conference on Drinking Water, Halifax (Nouvelle-Écosse), 27-30 avril 2002.
• Leuschner, J. et Beuscher, N. (1998) Studies on the mutagenic and carcinogenic potential of chloral hydrate. Arzneimittel-Forschung, 48 : 961-968.
• Lipscomb, J.C., Mahle, D.A., Brashear, W.T. et Garrett, C.M. (1996) A species comparison of chloral hydrate metabolism in blood and liver. Biochem. Biophys. Res. Commun., 227 : 340-350.
• Mailhes, J.B., Aardena, M.J. et Marchetti, F. (1993) Investigation of aneuploidy induction in mouse oocytes following exposure to vintablastine-sulfate, pyrimethamine, diethylstibestrol diphosphate, or chloral hydrate. Environ. Mol. Mutagen., 22 : 107-114.
• Marshall, E.K. et Owens, A.H. (1954) Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull. Johns Hopskins Hosp., 95 : 1-18.
• McEvoy, G.K. (1999) American Hospital Formulary Service Drug Information 99. American Society of Health-System Pharmacists, Inc., Bethesda, MD.
• Merdink, J.L., Stenner, R.D., Stevens, D.K., Parker, J.C. et Bull, R.J. (1999) Effect of enterohepatic circulation on the phamacokinetics of chloral hydrate and its metabolites in F344 rats. J. Toxicol. Environ. Health, 57 : 357-368.
• Moore, M.M. et Harrington-Brock, K. (2000) Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene. Environ. Health Perspect., 108 : 215-223.
• Natarajan, A.T., Duivenvooden, W.C., Meijers, M. et Zwanenburg, T.S. (1993) Induction of mitotic aneuploidy using Chinese hamster primary embryonic cells: Test results of 10 chemicals. Mutat. Res., 287(1) : 47-56.
• Newman, L.M. et Wackett, L.P. (1991) Fate of 2,2,2-trichloroacetaldehyde (chloral hydrate) produced during trichloroethylene oxidation by methanotrophs. Appl. Environ. Microbiol., 57 : 2399-2402.
• Ni, Y.C., Wong, T.Y., Lloyd, R.V., Heinze, T.M., Shelton, S., Casciano, D., Kadlubar, F.F. et Fu, P.P. (1996) Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab. Dispos., 24(1) : 81-90.
• NTP (National Toxicology Program) (2002a) Toxicology and carcinogenesis studies of chloral hydrate in B6C3F1 mice (gavage studies). NTP Technical Report Series 502, National Institutes of Health, Research Triangle Park, NC. 197 p.
• NTP (National Toxicology Program) (2002b) Toxicology and carcinogenesis studies of chloral hydrate (ad libitum and dietary controlled) in male B6C3F1 mice (gavage study). NTP Technical Report Series 503, National Institutes of Health, Research Triangle Park, NC. 218 p.
• Odum, J., Foster, J.-R. et Green, T. (1992) A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem.-Biol. Interact., 83(2) : 135-153.
• Ogino, K., Hobara, T., Kobayashi, H. et Iwamoto, S. (1990) Gastric mucosal injury by chloral hydrate. Toxicol. Lett., 52(2) : 129-133.
• PISC (Programme international sur la sécurité des substances chimiques) (2000) Chloral hydrate. Concise International Chemical Assessment Document No. 25, Organisation mondiale de la santé, Genève.
• Poon, R., Nadeau, B. et Chu, I. (2000) Biochemical effects of chloral hydrate on male rats following 7-day drinking water exposure. J. Appl. Toxicol., 20 : 455-461.
• Poon, R., Nakai, J., Yagminas, A., Benoit, F., Moir, D., Chu, I. et Valli, V.E. (2002) Subchronic toxicity of chloral hydrate on rats - a drinking water study. J. Appl. Toxicol., 22 : 227-236.
• Reid Crowther & Partners Ltd. (2000) Canadian water treatment study: water treatment and disinfection byproducts. Edmonton (Alberta). Septembre.
• Reynolds, J.E.F. et Prasad, A.B. (1982) Martindale - The extra pharmacopia. 28^e éd. The Pharmaceutical Press, Londres.
• Rijhsinghani, K.S., Abrahams, C., Swerdlow, M.A., Rao, K.V.N. et Ghose, T. (1986) Induction of neoplastic lesions in the livers of C57BL × C3HF1 mice by chloral hydrate. Cancer Detect. Prev., 9(3-4) : 279-288.
• Saillenfait, A.M., Langonne, I. et Sabate, J.P. (1995) Developmental toxicity of trichloroethylene, tetrachloroethylene and four of their metabolites in rat whole embryo cultures. Arch. Toxicol., 70 : 71-78.
• Sanders, V.M., Kauffman, B.M., White, K.L., Douglas, K.A., Barnes, D.W., Sain, L.E., Bradshaw, T.J., Borzelleca, J.F. et Munson, A.E. (1982) Toxicology of chloral hydrate in the mouse. Environ. Health Perspect., 44 : 137-146.
• Santé Canada (1994) Loi canadienne sur la protection de l'environnement. L'évaluation du risque sur la santé humaine des substances d'intérêt prioritaire. N^o En40-215/41F au catalogue, ministre des Approvisionnements et Services Canada, Ottawa (Ontario).
• Santé Canada (1995) Étude nationale sur les sous-produits de désinfection chlorés dans l'eau potable au Canada. Rapport n^o 95-DHM-197. Direction de l'hygiène du milieu, Santé Canada, Ottawa (Ontario).
• Sbrana, I., Di Sibio, A., Lomi, A. et Scarcelli, V. (1993) C-mitosis and numerical chromosome aberration analyses in human lymphocytes: 10 known or suspected spindle poisons. Mutat. Res., 287(1) : 57-70.
• Shapiro, S., Stone, D., Lewis, G.P. et Jick, H. (1969) Clinical effects of hypnotics. II. An epidemiological study. J. Am. Med. Assoc., 209 : 2016-2020.
• Stenner, R.D., Merdink, J.L., Fisher, J.W. et Bull, R.J. (1998) Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. Risk Anal., 18(3) : 261-269.
• U.S. EPA (Environmental Protection Agency des États-Unis) (1990) Draft Method 551. Determination of chlorination disinfection by-products and chlorinated solvents in drinking water by liquid-liquid extraction and gas chromatography with electron capture detection. Environmental Monitoring and Support Laboratory, Cincinnati, OH.
• U.S. EPA (Environmental Protection Agency des États-Unis) (1992) Technical Support Division Disinfection By-Products Field Study Database. Technical Support Division, Office of Ground Water and Drinking Water, Cincinnati, OH.
• U.S. EPA (Environmental Protection Agency des États-Unis) (1995) Methods for the determination of organic compounds in drinking water - Supplement III. EPA-600/R-95/131.
• U.S. EPA (Environmental Protection Agency des États-Unis) (1998a) National Primary Drinking Water Regulations; disinfectants and disinfection byproducts: Notice of data availability. 40 CFR Parts 141 and 142. Fed. Regist., 63(145) : 15674-15692.
• U.S. EPA (Environmental Protection Agency des États-Unis) (1998b) National Primary Drinking Water Regulations: disinfectants and disinfection byproducts. 40 CFR Parts 9, 141, and 142. Fed. Regist., 63 : 6904.
• U.S. EPA (Environmental Protection Agency des États-Unis) (1999) EPA guidance manual - Alternative disinfectants and oxidants. EPA-815-R-99-014. Washington, DC, avril.
• U.S. EPA (Environmental Protection Agency des États-Unis) (2000) Toxicological review of chloral hydrate. In support of summary information on the Integrated Risk Information System (IRIS). EPA/635/R-00/006.
• Verschueren, K. (2001) Handbook of environmental data on organic chemicals. 3^e éd. Van Nostrand Reinhold Co., New York, NY.
• Warr, T.J., Parry, E.M. et Parry, J.M. (1993) A comparison of two in vivo mammalian cell cytogenetic assays for the detection of mitotic aneuploidy using 10 known or suspect aneugens. Mutat. Res., 287(1) : 29-46.
• Waskell, L. (1978) A study of the mutagenicity of anesthetics and their metabolites. Mutat. Res., 57(2) : 141-153.
• Williams, D.T., LeBel, G.L. et Benoit, F.M. (1997) Disinfection by-products in Canadian drinking water. Chemosphere, 34 : 299-316.
• Xie, Y.F. (2004) Disinfection byproducts in drinking water: Formation, analysis, and control. Lewis Publishers, CRC Press, Boca Raton, FL.
• Yoon, J.S., Mason, J.M., Valencia, R., Woodruff, R.C. et Zimmering, S. (1985) Chemical mutagenesis testing in Drosophila. IV. Results of 45 coded compounds tested for the National Toxicology Program. Environ. Mutagen., 7 : 349-367.
• Zimmermann, T., Wehling, M. et Schulz, H.U. (1998) [Pharmacocinétique et biodisponibilité relative de l'hydrate de chloral et de ses métabolites.] Arzneimittelforschung, 48 : 5-12 (en allemand).